Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

7.450 +0.460 (+6.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
63 64 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Novavax Stock Skids As FDA Leaves Its Covid Vaccine Decision Hanging
Two days after advisors recommended the shot, the FDA has yet to make a move. 
Via Investor's Business Daily
Why Novavax Stock Is Falling Today
Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following reports that the U.S. Food and Drug Administration's decision on the company's COVID-19 vaccine could be delayed to review... 
Via Benzinga
HC Wainwright Says Non-mRNA COVID-19 Option Underappreciated
HC Wainwright says safety concerns were noted for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, but the strength of data showed that benefit outweighs risks. 
Via Benzinga
Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
Novavax, Inc (NASDAQ: NVAX) gapped up 10% to start the trading day on Wednesday, but at press time, the stock had given back almost all of its gains to trade mostly flat. 
Via Benzinga
Why This Novavax Analyst Remains Bearish After COVID Vaccine Panel Vote
A Bank of America analyst remains bearish on Novavax, Inc (NASDAQ: NVAX) after a regulatory panel approved Novavax’s Emergency Use Authorization request fo 
Via Benzinga
Top Penny Stocks Today: Why IMPP, CYRN and EFOI Are Soaring Wednesday
Penny stocks are a hot topic for traders today and we're diving into the top ones that investors will want to keep an eye on for Wednesday! 
Via InvestorPlace
NVAX Stock Price Predictions: Where Will Novavax Go From Here?
NVAX stock price predictions are in the spotlight after its vaccine got an unanimous recommendation from the FDA's advisory panel yesterday. 
Via InvestorPlace
Cruise Stocks News: Why Are CCL, RCL and NCLH Sliding Lower Today?
Cruise stocks are slipping on Wednesday after losing a battle with environmental groups over new carbon emissions regulations. 
Via InvestorPlace
Is NVAX Stock a Buy? What 3 Pros Say About Novavax Now.
Novavax (NVAX) stock is on the move Wednesday as investors react to an update from the FDA about its Covid-19 vaccine for adults. 
Via InvestorPlace
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Why Novavax Stock Is Trading Higher Today
Novavax Inc (NASDAQ: NVAX) shares are trading higher Wednesday after a committee of independent U.S. Food and Drug Administration (FDA) vaccine advisors voted to recommend Novavax's COVID-19 vaccine... 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, June 8
CNBC 
Via Benzinga
What's Next For Novavax Stock As COVID Vaccine Clears Key Hurdle In US
After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, investors! Another busy day of trading awaits and with that comes our biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
Gainers Cyren Ltd. (NASDAQ: CYRN) rose 31.1% to $2.32 in pre-market trading after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Down Ahead Of Wholesale Inventories Data
Pre-open movers 
Via Benzinga
5 Stocks To Watch For June 8, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Novavax's COVID-19 Vaccine For Adults Over 18 Backed By FDA Advisors: What's Next?
Novavax, Inc. (NASDAQ: NVAX) announced the U.S. 
Via Benzinga
Novavax Shares Gain Following FDA Advisory Committee's Positive Vote On Emergency Use Authorization (EUA) For COVID-19 Vaccine
Novavax’s (NASDAQ: NVAX) COVID-19 vaccine (NVX-CoV2373) receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee (VRBPAC), recommending... 
Via Benzinga
What's Going On With Novavax Stock Today?
Novavax Inc (NASDAQ: NVAX) shares have been halted since the pre-market session as the U.S. Food and Drug Administration holds a meeting to determine the fate of the company's COVID-19 vaccine. 
Via Benzinga
Novavax Stock Halted As FDA Mulls Its Rival To Covid Shots From Pfizer, Moderna
An FDA committee will vote on whether to recommend the shot based on its merits. 
Via Investor's Business Daily
Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted on Tuesday
We've seen a large array of halted stocks today as circuit breakers take effect to reign in unexpected volatility for some shares. 
Via InvestorPlace
Why Is Kiromic BioPharma (KRBP) Stock Up 75% Today?
Kiromic BioPharma (KRBP) stock is rocketing higher on Tuesday following announcing a new sponsored research agreement (SRA). 
Via InvestorPlace
SJM Stock in Focus as J.M. Smucker Anticipates $125 Million Hit From Peanut Butter Recalls
J.M. Smucker (SJM) stock is on the move today after the company revealed the expected impact of its recent peanut butter recalls. 
Via InvestorPlace
NVAX Stock Alert: 14 Things to Know as the Novavax Vaccine Faces the FDA Today
Novavax (NVAX) stock is in the news today as investors prepare for the results from the vaccine company's meeting with the FDA. 
Via InvestorPlace
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga's Premarket Brief On Trending Tickers: Amazon, Alibaba, DiDi, Solaredge, And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. 
Via Benzinga
69 Biggest Movers From Friday
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... 
Via Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
63 64 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.